Search all trials

Find therapies in clinical trials near you – page 28

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Glycogen storage disease type II

Not recruiting

InvestigationalNo placebo

Study on the Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Children with Late-onset Pompe Disease

InvestigationalNo placebo

Italy

Participants:0–17 years
Substances:Cipaglucosidase Alfa

Contact Research Centre

Acute lymphocytic leukaemia recurrent

Not recruiting

Registered drugNo placebo

Study of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Inotuzumab Ozogamicin

Contact Research Centre

Acute myocardial infarction

Not recruiting

Registered drug

Study to Test BI 765845 for Patients with Heart Attack

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Bi 765845

Contact Research Centre

B-cell type acute leukaemia

Not recruiting

InvestigationalNo placebo

Study on the Safety of Epcoritamab for Children and Young Adults with Relapsed or Refractory Aggressive B-cell Lymphomas

InvestigationalNo placebo

Italy

Participants:0–17 years
Substances:Epcoritamab

Contact Research Centre

Study of Ravulizumab for Children with Thrombotic Microangiopathy After Stem Cell Transplant

Not recruiting

Registered drugNo placebo

Study of Ravulizumab for Children with Thrombotic Microangiopathy After Stem Cell Transplant

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Ravulizumab

Contact Research Centre

Myelofibrosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Aprepitant

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

Investigational

Study on Nalbuphine ER for Treating Cough in Patients with Idiopathic Pulmonary Fibrosis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Nalbuphine Hydrochloride

Contact Research Centre

Pleural mesothelioma

Not recruiting

Registered drugNo placebo

Study of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Non-small cell lung cancer+1

Not recruiting

Registered drugNo placebo

Study Comparing Repotrectinib and Crizotinib for Patients with Advanced or Metastatic ROS1-positive Non-Small Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Crizotinib

Contact Research Centre

T-cell lymphoma

Not recruiting

InvestigationalNo placebo

Study of Tolinapant with Decitabine and Cedazuridine for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cedazuridine

Contact Research Centre

Cholangitis sclerosing

Not recruiting

InvestigationalNo placebo

Study on the Safety and Tolerability of A3907 for Adults with Primary Sclerosing Cholangitis (PSC)

InvestigationalNo placebo

Italy

Participants:18–64 years
Substances:A3907

Contact Research Centre

Find therapies in clinical trials near you – page 28

363 trials match your criteria

Glycogen storage disease type II

Study on the Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Children with Late-onset Pompe Disease

Acute lymphocytic leukaemia recurrent

Study of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia

Acute myocardial infarction

Study to Test BI 765845 for Patients with Heart Attack

B-cell type acute leukaemia

Study on the Safety of Epcoritamab for Children and Young Adults with Relapsed or Refractory Aggressive B-cell Lymphomas

Study of Ravulizumab for Children with Thrombotic Microangiopathy After Stem Cell Transplant

Study of Ravulizumab for Children with Thrombotic Microangiopathy After Stem Cell Transplant

Myelofibrosis

Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

Idiopathic pulmonary fibrosis

Study on Nalbuphine ER for Treating Cough in Patients with Idiopathic Pulmonary Fibrosis

Pleural mesothelioma

Study of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma

Non-small cell lung cancer

Study Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer

Non-small cell lung cancer+1

Study Comparing Repotrectinib and Crizotinib for Patients with Advanced or Metastatic ROS1-positive Non-Small Cell Lung Cancer

T-cell lymphoma

Study of Tolinapant with Decitabine and Cedazuridine for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

Cholangitis sclerosing

Study on the Safety and Tolerability of A3907 for Adults with Primary Sclerosing Cholangitis (PSC)

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.